| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 904 | $12.88 | $11,643.52 | -0.7% | -63.1% | - | |
| Aug 15, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,500 | $1.17 | $1,754.90 | +2.0% | -21.5% | - | |
| Aug 15, 2025 | BLFS Biolife Solutions Inc | Casdin Partners Master Fund, L.P.54 | 10% Owner | Sell | 500,000 | $24.40 | $12,200,000.00 | -6.9% | +3.3% | - | |
| Aug 15, 2025 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 12,500 | $42.32 | $528,987.50 | -1.4% | +6.5% | - | |
| Aug 15, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 277 | $86.81 | $24,046.37 | -0.8% | +21.3% | - | |
| Aug 15, 2025 | MYO Myomo, Inc. | Gudonis Paul R67 | Chief Executive Officer | Buy | 50,000 | $0.95 | $47,295.00 | +4.1% | -17.1% | - | |
| Aug 15, 2025 | DXCM Dexcom Inc | Foletta Mark G72 | Director | Sell | 2,750 | $81.06 | $222,902.82 | -2.6% | -26.2% | - | |
| Aug 15, 2025 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 243 | $12.88 | $3,129.84 | -0.6% | -63.1% | - | |
| Aug 15, 2025 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 383 | $12.88 | $4,933.04 | -0.8% | -63.1% | - | |
| Aug 15, 2025 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP, Chief Legal Officer | Sell | 500 | $80.29 | $40,145.00 | -0.5% | -26.2% | - | |
| Aug 15, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J49 | President And CEO | Buy | 14,083 | $0.79 | $11,170.52 | - | +1.9% | - | |
| Aug 15, 2025 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.54 | Director, 10% Owner | Buy | 358,220 | $1.24 | $443,032.57 | +0.2% | -2.4% | - | |
| Aug 14, 2025 | ESTA Establishment Labs Holdings Inc. | Lewin Nicholas Sheridan67 | Director | Buy | 2,600 | $37.85 | $98,410.00 | +15.8% | +66.5% | - | |
| Aug 14, 2025 | RDGL Vivos Inc | Korenko Michael K | CEO And President | Buy | 100,000 | $0.08 | $7,660.00 | +1.0% | - | - | |
| Aug 14, 2025 | VREX Varex Imaging Corp | Kunkel Jay K.53 | Director | Sell | 3,000 | $10.49 | $31,470.00 | -13.3% | +14.6% | - | |
| Aug 14, 2025 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Buy | 21,929 | $112.84 | $2,474,374.52 | +10.0% | +24.4% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Douglas Richard | - | Buy | 80,000 | $1.39 | $111,040.00 | +53.1% | +12.3% | - | |
| Aug 13, 2025 | ENOV Enovis Corp | Pryor Daniel A74 | EVP, Strategy &Business Dev. | Buy | 10,000 | $28.90 | $289,000.00 | +6.6% | +6.5% | - | |
| Aug 13, 2025 | PEN Penumbra Inc | Yuen Maggie49 | Chief Financial Officer | Sell | 2,000 | $250.00 | $500,000.00 | -13.4% | +8.7% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Brooke William W | - | Buy | 50,000 | $1.29 | $64,500.00 | +49.6% | +12.3% | - | |
| Aug 13, 2025 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Buy | 1,000 | $3.37 | $3,370.00 | +0.9% | +23.1% | - | |
| Aug 13, 2025 | AVNS Avanos Medical, Inc. | Blackford Gary | Director | Buy | 60,000 | $10.99 | $659,300.00 | +83.8% | +8.5% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Swirsky Douglas J | Chief Financial Officer | Buy | 50,000 | $1.29 | $64,500.00 | +44.7% | +12.3% | - | |
| Aug 13, 2025 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 50,000 | $25.11 | $1,255,500.00 | -63.8% | -35.2% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Erck Stanley C86 | - | Buy | 100,000 | $1.37 | $137,220.00 | +33.5% | +12.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.